Meeting to be held in New York on August 27 hosted by Jefferies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAMS:
- NewAmsterdam Pharma reports Q2 EPS (41c), consensus (58c)
- NAMS Upcoming Earnings Report: What to Expect?
- NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- NewAmsterdam Pharma’s Successful Obicetrapib Phase 3 Trial
- NewAmsterdam Pharma announces data from Phase 3 BROOKLYN trial